These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10560741)

  • 1. Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands.
    Haubmann C; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3143-6. PubMed ID: 10560741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.
    Huang Y; Kegeles LS; Bae S; Hwang D; Roth BL; Savage JE; Laruelle M
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1375-7. PubMed ID: 11378358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).
    Löber S; Hübner H; Utz W; Gmeiner P
    J Med Chem; 2001 Aug; 44(17):2691-4. PubMed ID: 11495580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors.
    Hidaka K; Matsumoto M; Tada S; Tasaki Y; Yamaguchi T
    Neurosci Lett; 1995 Feb; 186(2-3):145-8. PubMed ID: 7777184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356.
    Bergauer M; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1937-40. PubMed ID: 12113813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzamide bioisosteres incorporating dihydroheteroazole substructures: EPC synthesis and SAR leading to a selective dopamine D4 receptor partial agonist (FAUC 179).
    Einsiedel J; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2533-6. PubMed ID: 11549463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.
    Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jan; 9(1):97-102. PubMed ID: 9990464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and binding studies on a new series of arylpiperazino benzazol-2-one and benzoxazin-3-one derivatives as selective D4 ligands.
    Carato P; Depreux P; Lesieur D; Millan M; Newman-Tancredi A; Rettori MC; Caignard DH
    Drug Des Discov; 2000; 17(2):173-81. PubMed ID: 11045903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonists.
    Boyfield I; Brown TH; Coldwell MC; Cooper DG; Hadley MS; Hagan JJ; Healy MA; Johns A; King RJ; Middlemiss DN; Nash DJ; Riley GJ; Scott EE; Smith SA; Stemp G
    J Med Chem; 1996 May; 39(10):1946-8. PubMed ID: 8642552
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
    Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new selective dopamine D4 receptor ligand.
    Sampson D; Zhu XY; Eyunni SV; Etukala JR; Ofori E; Bricker B; Lamango NS; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2014 Jun; 22(12):3105-14. PubMed ID: 24800940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS; Tarazi FI; Baldessarini RJ; Xu L; Bakthavachalam V; Pounds S; True CD
    Eur J Pharmacol; 1999 Feb; 367(1):139-42. PubMed ID: 10082277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
    Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
    J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB
    Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.
    Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH
    J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist.
    Dubuffet T; Newman-Tancredi A; Cussac D; Audinot V; Loutz A; Millan MJ; Lavielle G
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2059-64. PubMed ID: 10450981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.